Skip to main content
Log in

Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

Abstract

The nonapeptide hormones arginine vasopressin (CYFQNCPRG-NH2, AVP) and oxytocin (CYIQNCPLG-NH2, OT), control many essential functions in mammals. Their main activities include the urine concentration (via stimulation of AVP V2 receptors, V2R, in the kidneys), blood pressure regulation (via stimulation of vascular V1a AVP receptors, V1aR), ACTH control (via stimulation of V1b receptors, V1bR, in the pituitary) and labor and lactation control (via stimulation of OT receptors, OTR, in the uterus and nipples, respectively). All four receptor subtypes belong to the GTP-binding (G) protein-coupled receptor (GPCR) family. This work consists of docking of YM087, a potent non-peptide V1aR and V2R – but not OTR – antagonist, into the receptor models based on relatively new theoretical templates of rhodopsin (RD) and opiate receptors, proposed by Mosberg et al. (Univ. of Michigan, Ann Arbor, USA). It is simultaneously demonstrated that this RD template satisfactorily compares with the first historical GPCR structure of bovine rhodopsin (Palczewski et al., 2000) and that homology-modeling of V2R, V1aR and OTR using opiate receptors as templates is rational, based on relatively high (20–60%) sequence homology among the set of 4 neurophyseal and 4 opiate receptors. YM087 was computer-docked to V1aR, V2R and OTR using the AutoDock (Olson et al., Scripps Research Institute, La Jolla, USA) and subsequently relaxed using restrained simulated annealing and molecular dynamics, as implemented in AMBER program (Kollman et al., University of California, San Francisco, USA). From about 80 diverse configurations, sampled for each of the three ligand/receptor systems, 3 best energy-relaxed complexes were selected for mutual comparisons. Similar docking modes were found for the YM087/V1aR and YM087/V2R complexes, diverse from those of the YM087/OTR complexes, in agreement with the molecular affinity data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jard, S., Elands, J., Schmidt, A. and Barberis, C., In Imura H. and Shizurne. K. (Eds.) Progress in Endocrinology, Excerpta Medica, Amsterdam, 1988, pp. 1183-1188.

    Google Scholar 

  2. Barberis, C. and Tribollet, E., Critical Rev. Neurobiol., 10 (1996) 119.

    Google Scholar 

  3. Freidinger, R.M. and Pettibone, D.J., Med. Res. Rev., 17 (1997) 1.

    Google Scholar 

  4. Manning, M. and Sawyer, W.H., J. Lab. Clin. Med., 114 (1989) 617.

    Google Scholar 

  5. Serradeil-Le Gal, C., Wagnon, J., Garcia, C., Lacour, C., Guiraudou, P., Chrostophe, B., Villanova, G., Nisato, D., Maffrand, J.P., Le Fur, G., Guillon, G., Cantau, B., Barberis, C., Trueba, M., Ala, Y. and Jard, S. J., Clin. Invest., 92 (1993)

  6. Yamamura, Y., Ogawa, H., Chihara, T., Kondo, K., Onogawa, T., Nakamura, S., Mori, T., Tominaga, M. and Yabuuchi, Y., Science, 252 (1991) 572.

    Google Scholar 

  7. Serradeil-Le Gal, C., Lacour, C., Valette, G., Garcia, G., Foulon, E., Galindo, G., Bankir, L., Pouzet, B., Guillon, G., Barberis, C., Chicot, D., Jard, S., Vilain, P., Garcia, C., Marty, E., Raufaste, D., Brossard, G., Nisato, D., Maffrand, J.P., and Le Fur, G., J. Clin. Invest., 98 (1996) 2729.

    Google Scholar 

  8. Yamamura, Y., Ogawa, H., Yamashita, H., Chihara, T., Miyamoto, H., Nakamura, S., Onogawa, T., Yamashita, T., Hosokawa, T., Mori, T., Tominaga, M. and Yabuuchi, Y., Br. J. Pharmacol., 105 (1992) 787.

    Google Scholar 

  9. Freidinger, R.F., Bock, M.G., Evans, B.E., Pettibone, D.J. and Williams, P.D. In Shimonishi, Y. (Ed.), Peptide science-present and future. Proceedings of the 1st International Peptide Symposium, Kyoto 30.11-5.12.97, Kluwer Acad. Publishers, Dordrecht, 1999, pp. 618-622.

    Google Scholar 

  10. Yatsu, T., Tomura, Y., Tahara, A., Wada, K., Tsukada, J., Uchida, W., Tanaka, A. and Takenaka, T., Eur. J. Pharm., 321 (1997) 225.

    Google Scholar 

  11. Matsuhisa, A., Taniguchi, N., Koshio, H., Yatsu, T., Tanaka, A., Chem. Pharm. Bull, 48 (2000) 21.

    Google Scholar 

  12. Pisvanis, J., Naitoh, M., Johnston, C.I., Burrel, L.M., Eur. J. Pharmacol., 381 (1999) 23.

    Google Scholar 

  13. Guderman, T., Neunberg, B. and Schultz, G., J., Mol. Med. 73 (1995) 51.

    Google Scholar 

  14. Wess, J., FASEB J., 11 (1997) 346.

    Google Scholar 

  15. Ji, T.H., Grossman, M. and Ji, I., J. Biol. Chem., 273 (1998) 17299.

    Google Scholar 

  16. Gether, U. and Kobilka, B.K., J. Biol. Chem., 273 (1998) 17979.

    Google Scholar 

  17. Bikker. J,A., Trumpp-Kallmeyer, S. and Humblet, C., J. Med. Chem. 41, (1998) 2911.

    Google Scholar 

  18. Ulloa-Aguirre, A., Stanislaus, D., Janovick, J.A. and Conn, P.M., Archiv. Med. Res., 30 (1999) 420.

    Google Scholar 

  19. Baldwin, J.M., EMBO J., 12 (1993) 1693.

    Google Scholar 

  20. Baldwin, J.M., Scheltler G.F.X., and Unger, V.M., J. Mol. Biol., 272 (1997) 144.

    Google Scholar 

  21. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Le Trong, I., Teller, D.C., Okada, T., Stenkamp, R.E., Yamamoto, M. and Miyano, M. Science 289 (2000) 739.

    Google Scholar 

  22. Schertler, G.F.X. and Hargrave, P.A., Proc. Natl. Acad. Sci., 92 (1995) 11578.

    Google Scholar 

  23. Unger, V.M. Hargrave, P.A. Baldwin, J.M. and Schertler, G.F.X., Nature, 389 (1997) 203.

    Google Scholar 

  24. Herzyk, P. and Hubbard, R.E., Biophys. J., 69 (1995) 2419.

    Google Scholar 

  25. Peitsch, M.C., Herzyk,P., Wells, T.N.C. and Hubbard, R. Automated G protein-coupled receptor modeling at Swiss-model, http://expasy.hcuge.ch/swissmod/SWISS-MODEL.html

  26. Iismaa, T.P., Biden, T.J. and Shine, J. G Protein-Coupled Receptors, Springer-Verlag, Heidelberg, 1995, Chapter 1.

    Google Scholar 

  27. Pogozheva, I.D., Lomize, A.L. and Mosberg, H.I., Biophys. J., 70 (1997) 1963.

    Google Scholar 

  28. Pogozheva, I.D., Lomize, A.L. and Mosberg, H.I., Biophys. J., 75 (1998) 612.

    Google Scholar 

  29. Morris, G.M., Goodsell, D.S., Huey, R. and Olson, A.J., J. Comput. Aid. Mol. Des., 10 (1996) 293.

    Google Scholar 

  30. AMBER 5.0, Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham III, T.E., Ross, W.S., Simmerling, C., Darden, T., Merz., K.M., Stanton, R.V., Cheng, A., Vincent, J.J., Crowley, M., Ferguson, D.M., Radmer, R., Seibel, G.L., Singh, U.C., Weiner, P.K. and Kollman, P.A. (1997) AMBER, v.5.0, University of California, San Francisco, CA, U.S.A.

    Google Scholar 

  31. SYBYL 6.1 (1994) Tripos Inc., 1699 S. Hanley Rd., St. Louis, MO 63144, USA.

  32. Fanelli, F., Barbier, P., Zanchetta, D., De Benedetti, P.G. and Chini, B., Mol. Pharmacol., 56 (1999) 214.

    Google Scholar 

  33. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P.G. and Cotecchia, S., EMBO J., 15 (1996) 3566.

    Google Scholar 

  34. Czaplewski, C., Kazmierkiewicz, R. and Ciarkowski, J., J. Comput. Aid. Mol. Design, 12 (1998) 275.

    Google Scholar 

  35. Schmidt, M.W., Baldridge, K.K., Boatz, J.A., Elbert, S.T., Gordon, M.S., Jensen, J.H., Koseki, S., Matsunaga, N., Nguyen, K.A., Su, S., Windus, T.L., Dupuis, M. and Montgomery, J.A., J. Comput. Chem., 14 (1993) 1347.

    Google Scholar 

  36. Bayly, C.I, Cieplak, P., Cornell, W.D. and Kollman, P., J. Phys. Chem., 97 (1993) 10269.

    Google Scholar 

  37. Koradi, R., Billeter, M., and Wüthrich, K., J. Mol. Graphics, 14 (1996) 51.

    Google Scholar 

  38. Corpet, F., Nucl. Acids Res., 16 (1988) 10881.

    Google Scholar 

  39. Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S. and Barberis C., J. Biol. Chem., 270 (1995) 25771.

    Google Scholar 

  40. Politowska, E., Czaplewski, C. and Ciarkowski, J., Acta Biochim. Pol., 46 (1999) 581.

    Google Scholar 

  41. Czaplewski, C, Kazmierkiewicz, R. and Ciarkowski, J., Acta Biochim. Pol., 45 (1998) 19.

    Google Scholar 

  42. Czaplewski, C, Kazmierkiewicz, R. and Ciarkowski, J., Lett. Peptide Sci. 5 (1998) 333.

    Google Scholar 

  43. Hibert, M., Hoflack, J., Trumpp-Kallmeyer, S., Mouillac, B., Chini, B., Mahé, E., Cotte, N., Jard, S., Manning, M. and Barberis, C.J., Rec. Signal Transd. Res., 19 (1999) 589.

    Google Scholar 

  44. Cotte, N., Balestre, M.-N., Aumelas, A., Mahé, E., Phalipou, S., Morin, D., Hibert, M., Manning, M., Durroux, T., Barberis, C. and Mouillac, B. Eur. J. Biochem., 267 (2000) 4253.

    Google Scholar 

  45. Chini, B., Mouillac, B., Ala, Y., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., Jard,S. and Barberis C., EMBO J., 14 (1995) 2176.

    Google Scholar 

  46. Thibonnier, M., Coles, P., Conarty, D.M., Plesnicher, C.L. and Shoham, M.J., Pharmol. Exp. Ther., 294 (2000) 195.

    Google Scholar 

  47. Babak, B., Souto, M.L., Imai, H., Shichida, Y. and Nakanishi, K., Science, 288 (2000) 2209.

    Google Scholar 

  48. Tahara, A., Tomura, Y., Wada, K.I., Kusayama, T., Tsukada, J., Takanashi, M., Yatsu, T., Uchida, W. and Tanaka, A., J. Pharmacol. Exp. Ther., 282 (1997) 301.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giełdoń, A., Kaźmierkiewicz, R., Ślusarz, R. et al. Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.. J Comput Aided Mol Des 15, 1085–1104 (2001). https://doi.org/10.1023/A:1015905822671

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015905822671

Navigation